Follow Us
© 2026 Arizent. All rights reserved.
(Bloomberg) — Some women who are at high risk of breast cancer, including those with a family history of the disease, should consider taking drugs to reduce their chances of getting cancer, a U.S. health advisory group says.
The drugs, tamoxifen and raloxifene, carry risks such as blood clots, stroke and cataracts, according to the U.S. Preventive Services Task Force, which released the draft recommendations on its website. The proposal is open for public comment until May 13.
For reprint and licensing requests for this article, click here.
As costs to treat serious conditions surge, employers must plan how to absorb budget-altering expenses ahead of time.
Bringing a procurement partner into the benefits planning process can offer greater insight and negotiation power, helping to reduce overall costs.
Health outcomes, costs and time away from work are improved when a cancer strategy leads to evidence-based care.
Benefits, policies and leadership support create trusted environments that help women and businesses succeed.
Jessica Domann has brought in more preventative care and created an external comprehensive cancer benefits guide for employees and their dependents.
